Family · Pharmaceutical analytical standards
Trimethadione
An anticonvulsant of the oxazolidinedione family, approved in the United States in January 1946 and effective mainly against absence seizures; it has been used especially for epilepsies resistant to other treatments. This family brings together the active ingredient.
Did you know?In the body it loses a methyl group and becomes dimethadione, the active metabolite, which stays in circulation much longer: a half-life of 6-13 days against 12-24 hours for the parent drug.
No product matches your search.
EDQM standards 1
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
